全文获取类型
收费全文 | 1160篇 |
免费 | 63篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 115篇 |
妇产科学 | 11篇 |
基础医学 | 89篇 |
口腔科学 | 37篇 |
临床医学 | 168篇 |
内科学 | 265篇 |
皮肤病学 | 16篇 |
神经病学 | 43篇 |
特种医学 | 214篇 |
外科学 | 72篇 |
综合类 | 40篇 |
预防医学 | 93篇 |
眼科学 | 8篇 |
药学 | 31篇 |
1篇 | |
肿瘤学 | 30篇 |
出版年
2020年 | 8篇 |
2019年 | 7篇 |
2018年 | 12篇 |
2017年 | 12篇 |
2016年 | 8篇 |
2015年 | 22篇 |
2014年 | 20篇 |
2013年 | 19篇 |
2012年 | 18篇 |
2011年 | 19篇 |
2010年 | 39篇 |
2009年 | 45篇 |
2008年 | 24篇 |
2007年 | 9篇 |
2006年 | 13篇 |
2005年 | 19篇 |
2004年 | 26篇 |
2003年 | 21篇 |
2002年 | 26篇 |
2001年 | 17篇 |
2000年 | 13篇 |
1999年 | 23篇 |
1998年 | 88篇 |
1997年 | 84篇 |
1996年 | 94篇 |
1995年 | 61篇 |
1994年 | 58篇 |
1993年 | 49篇 |
1992年 | 22篇 |
1991年 | 24篇 |
1990年 | 14篇 |
1989年 | 39篇 |
1988年 | 34篇 |
1987年 | 41篇 |
1986年 | 19篇 |
1985年 | 32篇 |
1984年 | 22篇 |
1983年 | 19篇 |
1982年 | 17篇 |
1981年 | 18篇 |
1980年 | 10篇 |
1979年 | 5篇 |
1978年 | 10篇 |
1977年 | 11篇 |
1976年 | 9篇 |
1975年 | 9篇 |
1973年 | 3篇 |
1972年 | 5篇 |
1971年 | 3篇 |
1970年 | 3篇 |
排序方式: 共有1234条查询结果,搜索用时 15 毫秒
1.
Simeprevir added to peginterferon and ribavirin lessens time with fatigue,depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST‐1, QUEST‐2 and PROMISE studies 下载免费PDF全文
J. Scott L. Gilles M. Fu E. Brohan C. Panter R. Arbuckle W. Jessner M. Beumont 《Journal of viral hepatitis》2015,22(8):639-650
The value of adding simeprevir (SMV) vs placebo (PBO) to peginterferon and ribavirin (PR) for treatment of chronic hepatitis C virus infection was examined using patient‐reported outcomes (PROs); further, concordance of PROs with virology endpoints and adverse events (AEs) was explored. Patients (n = 768 SMV/PR, n = 393 PBO/PR) rated fatigue (FSS), depressive symptoms (CES‐D) and functional impairment (WPAI: Hepatitis C Productivity, Daily Activity and Absenteeism) at baseline and throughout treatment in three randomised, double‐blind trials comparing the addition of SMV or PBO during initial 12 weeks of PR. PR was administered for 48 weeks (PBO group) and 24/48 weeks (SMV group) using a response‐guided therapy (RGT) approach. Mean PRO scores (except Absenteeism) worsened from baseline to Week 4 to the same extent in both groups but reverted after Week 24 for SMV/PR and only after Week 48 for PBO/PR. Accordingly, there was a significantly lower area under the curve (baseline–Week 60, AUC60) and fewer weeks with clinically important worsening of scores in the SMV/PR group at any time point. Incidences of patients with fatigue and anaemia AEs were similar in both groups, but FSS scores showed that clinically important increases in fatigue lasted a mean of 6.9 weeks longer with PBO/PR (P < 0.001). PRO score subgroup analysis indicated better outcomes for patients who met the criteria for RGT or achieved sustained virological response 12 weeks post‐treatment (SVR12); differences in mean PRO scores associated with fibrosis level were only observed with PBO/PR. Greater efficacy of SMV/PR enabled reduced treatment duration and reduced time with PR‐related AEs without adding to AE severity. 相似文献
2.
PJ Commerford 《Cardiovascular journal of Africa》2015,26(4):151-Aug;26(4):151
3.
Hans Bosma Martin PJ van Boxtel Gertrudis IJM Kempen Jacques ThM van Eijk Jelle Jolles 《BMC public health》2007,7(1):179
Background
The aims of this study were to examine the extent to which higher intellectual abilities protect higher socio-economic groups from functional decline and to examine whether the contribution of intellectual abilities is independent of childhood deprivation and low birth weight and other socio-economic and developmental factors in early life. 相似文献4.
5.
6.
Previous reports in the literature have described correlation of increasing repeat length with severity of the phenotype, in Kennedy syndrome. We describe male siblings with different repeat lengths, with lack of expression of the phenotype in the sibling with the longer repeat length. The phenotype was identical to motor neurone disease. There is variability of expression in Kennedy syndrome and repeat length even in siblings cannot be taken as a conclusive indicator of severity. CAG repeat length cannot be used to predict the natural history of Kennedy disease. The diagnosis of Kennedy syndrome should be considered in male patients presenting with atypical motor neurone disease. 相似文献
7.
PJ Woll PhD MRCP R Pettengell PhD FRACP 《International journal of clinical practice》1997,51(2):111-115
SUMMARY The interferons are natural glycoproteins secreted in response to various stimuli, including viral infection. They have antiviral, antiproliferative and immunomodulatory effects on different target cell populations. Since recombinant human interferons have become available, they have been tested in a wide range of malignancies. They are well established in the treatment of hairy cell leukaemia, chronic myelogenous leukaemia and multiple myeloma. Although they have documented activity against lymphoma, melanoma, renal cell cancer and carcinoid tumours, their role in the treatment of these tumours is less clear. In the common solid tumours, such as lung cancer and colorectal cancer, the use of interferons remains experimental. Here we will summarise their practice applications in oncology, using randomised studies where available to establish their place in multi-modality treatment. We will not discuss their use as antiviral or immunomodulating agents in viral and autoimmune diseases, multiple sclerosis or after organ transplantation. 相似文献
8.
9.
10.